Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Imatinib may stop the growth of tumor cells by blocking some of the enzymes needed
for cell growth. Drugs used in chemotherapy, such as capecitabine and cisplatin, work in
different ways to stop the growth of tumor cells, either by killing the cells or by stopping
them from dividing. Giving imatinib together with combination chemotherapy may kill more
tumor cells.
PURPOSE: This phase I trial is studying the side effects and best dose of imatinib when given
together with capecitabine and cisplatin in treating patients with unresectable or metastatic
stomach cancer.